Denali Therapeutics Inc.
METHODS FOR TREATING DYSREGULATED LIPID METABOLISM
Last updated:
Abstract:
Certain embodiments described herein provide a method for treating dysregulated lipid metabolism and/or inflammation in a mammal in need thereof, comprising administering to the mammal an effective amount of an agonist anti-triggering receptor expressed on myeloid cells 2 (TREM2) antibody.
Status:
Application
Type:
Utility
Filling date:
26 Nov 2019
Issue date:
27 Jan 2022